Orthox Obtains MHRA Approval to Commence FFLEX Study On July 14, 2022, Orthodox Ltd, a clinical-stage company created medical implants to treat orthopedic problems including damaged knee arti...
Byondis Files its HER2-Targeting Antibody-Drug Conjugate (ADC) Trastuzumab Duocarmazine in the US and Europe Byondis has filed for clearance of its HER2-targeting antibody-drug conjugate (ADC) trastuzumab duocarmazine in the United States and Europe, setting up a battle with heavyweight competitors Roche and Ast...
Find MoreZsquare ENT-Flex™ Rhinolaryngoscope, the First High-Performance Single-Use ENT Endoscope of Zsquare received FDA Clearance On July 06, 2022, Zsquare, one of the leading developers of high-performance, single-use endoscopes, received Food and Drug Administration 510K clearance to market its first product, the Zsq...
Find MoreNovo Nordisk Reports Phase III Results of Concizumab Drug for Hemophilia A or B Novo Nordisk has announced Phase III results for their concizumab drug for hemophilia A or B, demonstrating efficacy in preventing bleeding events and paving the way for regulatory filings later this year. Concizumab, an anti-tissue ...
Find MoreIpsen to Buy Biopharmaceutical Company Epizyme for USD 247 Million The restructuring of French manufacturer Ipsen has progressed with a takeover agreement for US competitor Epizyme and its cancer drug Tazverik in a deal for slightly less than USD 250 million. Ipsen is proposing USD 1.45 per share for Epizyme, va...
Find MoreConformal Medical Announces Launch of CONFORM Pivotal Trial On June 17, 2022, Conformal Medical Inc, is a medical device company manufacturing devices to avoid strokes in patients with non-valvular atrial fibrillation and developing next-generation LAAO technology. Its exclusive technology is intended to make le...
Find MoreBiogen terminates USD 217 Million ALS Pact with Karyopharm Biogen has backed out of the four-year-old partnership with Karyopharm on a drug candidate for the neurological disease amyotrophic lateral sclerosis, which could have cost the US biotech up to USD 217 million. The 2018 agreement that granted Biogen righ...
Find MoreUS FDA Grants 510K Clearance for Aurora Spine’s Interbody Fusion Device On June 07, 2022, Aurora Spine, Inc. a designer and manufacturer of innovative medical devices, is an emerging growth company focused on delivering new solutions to the spinal implant and pain management industries through a series of screwl...
Find MoreGSK Starts Preparations for Regulatory Filings as RSV Vaccine Clears Phase III Test in Adults GSK plans to initiate preparation for regulatory submissions for its respiratory syncytial virus (RSV) vaccine after the vaccine performed well in the much-anticipated AReSVi 006 trial in individuals aged 60 and above.&...
Find MorePositive Results Report REVIAN RED System as a Possible Treatment for Central Centrifugal Cicatricical Alopeciain African American Women On June 02, 2022, REVIAN Inc., an aesthetic medical technology company focused on stimulating the body's natural processes in order to rejuvenate hair and skin with light relea...
Find MoreThough Covid-19 has a significant impact on the supply chain, input costs, logistics, and raw materi.....
Find MorePostoperative Pain is the pain that an individual experiences after a major operation or surgical pr.....
Find MoreCocaine Use Disorder (CUD) is characterized as a substance use disorder in which biological, psychol.....
Find MoreAcute myeloid leukemia (AML), also called acute myelogenous leukemia and acute nonlymphocytic leukem.....
Find MoreCachexia is a complicated metabolic syndrome related to underlying illness and characterized by musc.....
Find MoreChlamydial Infection is caused by Chlamydia species and is the most common sexually transmitted bact.....
Find MoreThe American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.